Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GOLDEN TOXICOLOGY LLC

NPI: 1285011403 · WEST LINN, OR 97068 · Clinical Medical Laboratory · NPI assigned 04/27/2015

$1.13M
Total Medicaid Paid
17,374
Total Claims
17,154
Beneficiaries
23
Codes Billed
2018-01
First Month
2022-12
Last Month

Provider Details

Authorized OfficialNOLES, DODIE (OPERATIONS MANAGER)
NPI Enumeration Date04/27/2015

Related Entities

Other providers sharing the same authorized official: NOLES, DODIE

ProviderCityStateTotal Paid
KOLPIA COUNSELING SERVICE ASHLAND OR $582K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 10,105 $571K
2019 3,408 $266K
2020 2,018 $167K
2021 1,001 $72K
2022 842 $52K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 3,258 3,229 $307K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,698 3,651 $233K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 1,260 1,244 $218K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,705 1,703 $105K
80361 435 428 $20K
80362 435 428 $20K
80346 435 428 $19K
80357 434 427 $18K
80369 435 428 $18K
80358 435 428 $16K
80324 435 428 $16K
80353 435 428 $15K
80359 435 428 $14K
80372 435 428 $14K
80348 435 428 $14K
80365 435 428 $14K
80354 434 427 $14K
80335 421 414 $14K
80373 435 428 $14K
80345 434 427 $12K
80349 159 152 $5K
80350 159 152 $5K
83992 192 192 $3K